Print

Molecular Response (MRL) Announces Key Agreement in Translational Oncology with SuperGen, Inc. (SUPG)  
7/27/2011 10:53:39 AM

SAN DIEGO--(BUSINESS WIRE)--Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today an agreement with SuperGen, Inc.
//-->